The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update

BACKGROUND: The 2017 Alzheimer’s disease (AD) Strategic Biomarker Roadmap (SBR) structured the validation of AD diagnostic biomarkers into 5 phases, systematically assessing analytical validity (Phases 1–2), clinical validity (Phases 3–4), and clinical utility (Phase 5) through primary and secondary...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Eur J Nucl Med Mol Imaging
Main Authors: Boccardi, Marina, Dodich, Alessandra, Albanese, Emiliano, Gayet-Ageron, Angèle, Festari, Cristina, Ashton, Nicholas J., Bischof, Gérard N., Chiotis, Konstantinos, Leuzy, Antoine, Wolters, Emma E., Walter, Martin A., Rabinovici, Gil D., Carrillo, Maria, Drzezga, Alexander, Hansson, Oskar, Nordberg, Agneta, Ossenkoppele, Rik, Villemagne, Victor L., Winblad, Bengt, Frisoni, Giovanni B., Garibotto, Valentina
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2021
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8175304/
https://ncbi.nlm.nih.gov/pubmed/33688996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-020-05120-2
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki